SUBSCRIBE
SUBSCRIBE
News   Deals

Merck & Co., Inc. Announces Completion of Acquisition Of Sirna Therapeutics, Inc.

December 29, 2006 | 
1 min read
WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck & Co., Inc. (NYSE: MRK) today announced that it has successfully completed the acquisition of Sirna Therapeutics, Inc. (NASDAQ: RNAI) in a cash transaction which closed in the fourth quarter of 2006.
Mergers & acquisitions
MORE ON THIS TOPIC
China High Resolution Innovation Concept
Insights
Uptick in Dealmaking, Chinese Partnerships Drive Biotech’s Comeback
December 17, 2025
 · 
3 min read
 · 
Jennifer Smith-Parker
Pictured: Blue Sanofi sign on building in Germany at night
Alzheimer’s disease
Sanofi’s Neuro Push Arrives in Seoul With $1B+ Alzheimer’s Play
December 16, 2025
 · 
1 min read
 · 
Tristan Manalac
Illustration of businessman running back around
Autoimmune disease
Sanofi Taps Dren Again in up to $1.7B Autoimmune Partnership
December 15, 2025
 · 
1 min read
 · 
Annalee Armstrong
Rheumatoid arthritis (RA) commonly causes inflammation in the hands, leading to pain, swelling, and stiffness in the joints, particularly the small joints of the fingers and wrists. This inflammation results from the immune system attacking the body's own joint tissues, causing the synovium (lining of the joint) to become inflamed and release chemicals that damage nearby tissues.
Mergers & acquisitions
Sobi Makes $1.5B Gout Play With Arthrosi Acquisition
December 15, 2025
 · 
2 min read
 · 
Tristan Manalac